What is the equity of Mediwound this year?
Mediwound has equity of 31.59 M USD this year.
Mediwound Equity 2025
Mediwound Equity
31.59 M USD
Ticker
MDWD
ISIN
IL0011316309
WKN
A110TG
In 2025, Mediwound's equity was 31.59 M USD, a 189.6% increase from the 10.91 M USD equity in the previous year.
Mediwound Aktienanalyse
What does Mediwound do?
Mediwound Ltd is an Israeli company specializing in the development and marketing of therapies for chronic and acute wounds. The company was founded in 2000 and is headquartered in Yavne, Israel. Its history began with the idea of developing an innovative treatment method for burns. The company collaborated closely with the Israeli Ministry of Defense to find a better method for wound treatment. The result was the product NexoBrid, an enzymatic debridement treatment that aims to remove dead tissue from burn wounds to enable faster healing. Mediwound's business model is to develop and market innovative drugs and therapy solutions for wounds. The company operates in several areas, including burn wounds, chronic wounds, and trauma wounds. In the burn wounds sector, Mediwound offers the product NexoBrid, which enzymatically removes dead tissue from burns and eliminates neurotoxic substances that can damage wound healing if left in the tissue for too long. NexoBrid is already approved in several countries, including the USA and European countries. In the chronic wounds sector, Mediwound offers the product EscharEx, which is used to treat chronic wounds such as pressure ulcers, diabetic foot ulcers, and venous leg ulcers. EscharEx also uses an enzymatic approach and aims to remove dead tissue to enable the body's natural healing process. There are plans to launch EscharEx in Europe in the second half of 2021. Mediwound also operates in the trauma wounds sector and received the product MWPC003 in Europe in 2020. It is a novel enzymatic debriding product that can be used in the integrated therapy of complex trauma wounds with additional topical treatment options. Through the development of innovative therapies and drugs, Mediwound has established itself as a reliable partner in wound treatment. The company continues to focus on innovation and plans to expand its product range in the future. Overall, Mediwound Ltd is a groundbreaking company in the field of wound care. The company's products and solutions contribute to faster and more effective wound healing, improving the lives of patients worldwide. Mediwound ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Mediwound's Equity
Mediwound's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Mediwound's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Mediwound's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Mediwound's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Mediwound’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Mediwound stock
What was the equity of Mediwound compared to the previous year?
The equity of Mediwound has increased/decreased by 189.6% increased compared to the previous year.
What impact does a high equity have on investors of Mediwound?
A high equity is advantageous for investors of Mediwound as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Mediwound?
A low equity can be a risk for investors of Mediwound, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Mediwound affect the company?
An increase in equity of Mediwound can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Mediwound affect the company?
A reduction in equity of Mediwound can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Mediwound?
Some factors that can affect the equity of Mediwound include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Mediwound so important for investors?
The equity of Mediwound is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Mediwound take to change the equity?
To change equity, Mediwound can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Mediwound pay?
Over the past 12 months, Mediwound paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mediwound is expected to pay a dividend of 0 USD.
What is the dividend yield of Mediwound?
The current dividend yield of Mediwound is .
When does Mediwound pay dividends?
Mediwound pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Mediwound?
Mediwound paid dividends every year for the past 0 years.
What is the dividend of Mediwound?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Mediwound located?
Mediwound is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mediwound kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mediwound from 1/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 1/4/2025.
When did Mediwound pay the last dividend?
The last dividend was paid out on 1/4/2025.
What was the dividend of Mediwound in the year 2024?
In the year 2024, Mediwound distributed 0 USD as dividends.
In which currency does Mediwound pay out the dividend?
The dividends of Mediwound are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Mediwound
Our stock analysis for Mediwound Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mediwound Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
